We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hypothermia Emergency Vest Protects Against Neurological Damage

By HospiMedica International staff writers
Posted on 19 Jul 2012
Textile cooling pads positioned in an emergency vest could help prevent neurological damage after successful resuscitation of cardiac arrest patients. More...


Researchers at the Hohenstein Institute (Boennigheim, Germany) have developed a novel instantaneous cooling system based on the mineral zeolite and proprietary water adsorption technology. The technology utilizes waterproof, airtight, hollow textile cooling pads filled with water that are integrated into a vest. The cooling pads are connected to a metal container maintained in a vacuum that contain the silicate mineral zeolite. When an interposed valve is opened, the water in the pads is instantly cooled down to nearly freezing, thus effectively draining heat from the patient's body.

The cooling system based on the zeolite/water adsorption technology has a simple design that does not require electrical power, and can be used in any location, offering drastic lowering of the core body temperature to 32-34 °C. Such rapid cooling has been proven to protect the brain against irreparable neurological damage after occurrence of a cardiac arrest. The cooling pads are intended to complement mobile defibrillators with automated electrocardiogram (ECG) analysis for use by first aiders without medical knowledge.

“The cooling pads harbor enormous potential in the neurological rehabilitation after cardiac arrests,” said Prof. Dirk Höfer, PhD, of the faculty of hygiene, environment, and medicine. “In addition to the benefits for the affected individual, every prevented case of invalidity is also a great financial advantage for the general public.”

Related Links:
Hohenstein Institute


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.